Prediction of disease relapses by multibiomarker disease activity and autoantibody status in patients with rheumatoid arthritis on tapering DMARD treatment

OBJECTIVE: To analyse the role of multibiomarker disease activity (MBDA) score in predicting disease relapses in patients with rheumatoid arthritis (RA) in sustained remission who tapered disease modifying antirheumatic drug (DMARD) therapy in RETRO, a prospective randomised controlled trial. METHOD...

Descripción completa

Detalles Bibliográficos
Autores principales: Rech, Juergen, Hueber, Axel J, Finzel, Stephanie, Englbrecht, Matthias, Haschka, Judith, Manger, Bernhard, Kleyer, Arnd, Reiser, Michaela, Cobra, Jayme Fogagnolo, Figueiredo, Camille, Tony, Hans-Peter, Kleinert, Stefan, Wendler, Joerg, Schuch, Florian, Ronneberger, Monika, Feuchtenberger, Martin, Fleck, Martin, Manger, Karin, Ochs, Wolfgang, Schmitt-Haendle, Matthias, Lorenz, Hanns-Martin, Nuesslein, Hubert, Alten, Rieke, Henes, Joerg, Krueger, Klaus, Schett, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013080/
https://www.ncbi.nlm.nih.gov/pubmed/26483255
http://dx.doi.org/10.1136/annrheumdis-2015-207900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5013080/
https://www.ncbi.nlm.nih.gov/pubmed/26483255
http://dx.doi.org/10.1136/annrheumdis-2015-207900

Ejemplares similares